Authorities allege the scheme extracted millions through wound-care billing and referral kickbacks
WASHINGTON, DC — Sarasota advanced practice registered nurse Leigh Tesar remains free pending trial under a $1 million unsecured appearance bond after federal agents arrested her June 18 in a Medicare wound-care fraud and alleged referral-kickback prosecution.
The arrest followed a grand jury indictment filed one day earlier, and the resulting court proceedings combined an initial appearance, arraignment, detention hearing, and release decision within a fast-moving twenty-four-hour sequence in Tampa federal court.
The official Middle District of Florida announcement alleges that Tesar, Walter Presha Junior, and Koby Evans participated in a wound-care operation that submitted more than $118 million in Medicare claims and received approximately $61 million.
Tesar’s release does not resolve whether any claim was false, any treatment was unnecessary, or any payment constituted a kickback, because a federal bond determination addresses pretrial appearance and safety, not guilt or innocence.
Available public docket summaries reviewed through August 10 show no subsequent order revoking Tesar’s release, while a July continuance moved the case from an anticipated August trial period into the January 2027 trial term.
June 18 produced several procedural developments
The indictment was filed June 17 under case number 8:26-cr-00216-MSS-LSG, charging Tesar in counts one through eight and assigning different conspiracy or kickback-receipt allegations to Presha and Evans within the same ten-count prosecution.
A later docket entry records that the arrest warrant for Tesar was executed June 18, establishing the arrest date independently from the Justice Department’s broader public announcement, which appeared during the coordinated national enforcement rollout.
Tesar then appeared before United States Magistrate Judge Natalie Hirt Adams for an initial appearance, arraignment, and detention hearing, after which the court orally granted a defense request for release from federal custody under specified conditions.
Five counts accuse Tesar of health care fraud, one count alleges a conspiracy to defraud the United States and exchange health care kickbacks, and two substantive counts accuse her of offering or paying prohibited remuneration.
Presha and Evans are each charged in the conspiracy count, while separate substantive counts accuse Presha and Evans respectively of receiving referral-linked payments through business accounts associated with their purported sales or health care activities.
Local reporting based upon court records said all three defendants were arrested and released June 18 during their first appearances, identifying Tesar’s bond as $1 million, Presha’s as $250,000, and Evans’s as $100,000.
Nothing in that same-day release sequence establishes that Tesar deposited $1 million in cash, purchased a commercial surety bond, or pledged property worth that amount before leaving custody, because her appearance bond was unsecured.
The $1 million figure was an unsecured promise
An unsecured appearance bond generally obligates a defendant to pay the stated amount if required conditions are breached, particularly through a failure to appear, without requiring the entire sum to be deposited with the court beforehand.
That structure differs from a secured bond supported by cash, property, or a surety, and the distinction matters when headlines otherwise suggest that a wealthy defendant simply paid a seven-figure price for freedom.
The court’s choice nevertheless carried meaningful consequences, because Tesar assumed a potentially substantial financial obligation while remaining subject to judicial supervision, required appearances, travel limitations, and any additional conditions in the written release order.
The $1 million amount is not a fine, restitution award, forfeiture judgment, settlement payment, or estimate of Medicare loss, and prosecutors cannot collect it as punishment merely because they obtained an indictment containing serious financial allegations.
Readers should also distinguish the bond from the government’s separately reported asset seizures, because one mechanism seeks to assure lawful participation in pending proceedings while the other preserves disputed property for later tracing and forfeiture litigation.
Although the bond amount attracts attention, federal release law generally directs judges toward conditions reasonably calculated to secure appearance and protect the community, while forbidding the transformation of unattainable financial conditions into automatic detention by another name.
Accordingly, accurate descriptions should say that Tesar was released on a $1 million unsecured bond, not that she paid $1 million, posted $1 million in cash, bought her release, or satisfied any alleged government loss.
Travel restrictions made the release conditional
The written release order restricted Tesar’s travel to the Middle District of Florida, a geographically broad federal district that includes Sarasota and Tampa but does not provide unrestricted permission to travel elsewhere without judicial approval.
Tesar’s counsel subsequently filed travel motions on June 30 and July 7, demonstrating that the geographical limitation had practical force and that proposed departures from the district required a formal request rather than unilateral personal discretion.
The July 7 filing sought permission for travel from July 10 through July 13, while describing the unsecured bond and district restriction as existing release conditions that the defense asked the magistrate judge to modify temporarily.
Those filings should not be characterized as violations, because requesting advance authorization is the procedural method contemplated by a travel restriction, and a motion alone does not establish whether the court ultimately granted every requested itinerary or condition.
Travel requests can prompt consideration of destination, purpose, duration, transportation, accommodations, supervising-officer views, government objections, and return plans, allowing the court to balance legitimate personal needs against continued assurance of appearance under supervision.
The motions also illustrate why release and unrestricted liberty are not synonymous, since a defendant may live outside custody while remaining subject to geographic boundaries, reporting obligations, contact restrictions, and continuing judicial authority over changed circumstances.
No publicly accessible entry reviewed for this update identifies a bond revocation or new detention order against Tesar, so the available record still describes supervised pretrial release rather than incarceration following an alleged violation.
Three bond amounts do not rank culpability
Tesar’s $1 million unsecured figure exceeded the reported amounts assigned to Presha and Evans, but that numerical difference does not establish that she is five or ten times more culpable than either co-defendant.
Judges considering pretrial release can examine alleged offense characteristics, financial resources, community and family ties, employment, criminal history, court-appearance history, available supervision, proposed travel, local roots, and other information bearing upon future compliance.
The indictment also assigns Tesar more substantive counts and places her at the center of Primecare’s alleged billing activity, circumstances that may help explain greater judicial caution without converting the release hearing into a miniature criminal trial.
Presha’s and Evans’s same-day releases similarly do not validate or weaken the accusation that they received kickbacks, because their respective bond decisions concern managing pretrial risks rather than evaluating the government’s ultimate proof beyond a reasonable doubt.
Different bond amounts within one prosecution are therefore individualized procedural decisions, not sentencing forecasts, damages calculations, public rankings of wrongdoing, or reliable predictions about which defendant may later plead, proceed to trial, or prevail.
The fact that all three defendants returned home after their appearances means only that the court found release conditions acceptable at that stage, subject to continuing compliance, modification, and possible enforcement throughout the litigation.
The trial schedule now extends into 2027
The June 18 courtroom minutes initially placed the matter within an August 2026 trial term, creating a compressed schedule that quickly proved unrealistic for a case involving extensive medical, billing, financial, corporate, and electronic evidence.
A government status report filed July 15 advised that the parties anticipated requesting a continuance into January, while a subsequent unopposed defense motion cited recently delivered discovery productions and the time required for meaningful review.
On July 22, the district court continued the proceeding as to all three defendants into the January 2027 trial term, which begins January 11, while directing the filing of appropriate speedy-trial waivers covering the extended period.
That continuance makes Tesar’s bond status more consequential because release conditions may now govern for several additional months while lawyers inspect records, retain experts, litigate motions, negotiate stipulations, and prepare competing interpretations of the alleged transactions.
A delayed trial does not signal prosecutorial weakness or defense obstruction on its own, especially when discovery may include thousands of claims, clinical charts, wound photographs, product invoices, bank records, messages, audit materials, and business documents.
The speedy-trial framework permits justified exclusions when a judge finds that additional preparation serves the interests of justice, although defendants must knowingly address applicable rights and the court must create an adequate procedural record.
The January term remains a scheduling target rather than a guaranteed opening date, since later motions, discovery disputes, plea developments, expert needs, severance questions, evidentiary hearings, or additional continuances could again alter the courtroom calendar.
The indictment describes an eighteen-month billing operation
Prosecutors allege that from approximately May 2024 through November 2025, Tesar and others caused Medicare to receive more than $118 million in claims involving wound-care products and services furnished through Tesar Primecare in Sarasota.
The government says Medicare paid more than $61 million after claims represented that expensive allografts and related services were medically necessary, reimbursable under applicable rules, actually supplied as described, and untainted by prohibited referral compensation.
Five health care fraud counts identify selected beneficiaries and transactions totaling approximately $3.96 million billed and approximately $2.82 million paid, giving prosecutors patient-specific executions within the much larger aggregate scheme alleged elsewhere in the indictment.
Those selected claims do not automatically prove the remaining billing universe fraudulent, just as the broader $118 million figure cannot replace evidence connecting each charged execution with a materially false representation and Tesar’s required knowledge.
The indictment advances several distinct falsity theories, including allografts described as medically unnecessary, applications allegedly unsupported by required conservative care, services purportedly performed under ineligible clinical circumstances, and applications prosecutors say never occurred.
It further alleges that patient records were falsified to describe earlier treatment, medical documentation, conditions, or applications that would make advanced products appear eligible, reasonable, necessary, and properly represented to the Medicare contractor.
At trial, the government must transform those grand jury allegations into admissible evidence, while the defense may challenge medical judgments, documentation interpretations, claim coding, authorship, materiality, causation, payment calculations, and alleged criminal intent.
Referral allegations form the proposed financial loop
The conspiracy theory identifies an unnamed Pennsylvania distributor that marketed allografts to Tesar and Primecare while engaging Presha, Evans, and others through purported representative arrangements that appeared to be ordinary commercial sales relationships.
Prosecutors contend those arrangements were shams that compensated beneficiary referrals, allowing Tesar to obtain wound-care patients, submit high-value Medicare claims, pay the distributor for products, and direct calculated value back toward credited representatives.
According to the indictment, Tesar sent Presha messages in September 2024 identifying more than $4.06 million in invoices and pairing that figure with a twenty-percent calculation approaching $813,925, which prosecutors characterize as referral-related accounting.
The charging document also describes January 2025 conversations comparing products priced at approximately $1,591 and $2,000 per square centimeter, while allegedly calculating how the more expensive selection would increase a representative’s anticipated twenty-percent share.
On August 15, 2025, the distributor allegedly transferred approximately $397,570 into an account associated with Presha and approximately $10,998 into an account associated with Evans, producing separate payment and receipt counts across the same two transactions.
The defense can seek evidence of legitimate marketing, sales support, education, account development, inventory work, fair-market compensation, and independent clinical decisions, while prosecutors must prove that remuneration knowingly rewarded federally reimbursable referrals for patient business.
Because one payment event can support allegations against both a payer and recipient, jurors would need instructions separating Tesar’s alleged conduct from each nurse’s knowledge, purpose, services, communications, and individual relationship with the distributor.
Patient-care allegations carry exceptional sensitivity
The government alleges that allografts were sometimes applied without completed conservative treatment, placed on infected wounds, continued after clear nonresponse, selected to maximize profit, or used where terminal illness supposedly made healing unattainable.
It separately claims some billed applications never happened at all, an accusation that differs sharply from a disagreement over medical necessity because the contested issue becomes whether the represented clinical event occurred on the billed date.
Prosecutors may compare treatment schedules, product orders, inventory, photographs, lot numbers, electronic metadata, caregiver accounts, employee testimony, and claim timestamps when attempting to determine whether individual applications were performed exactly as represented on billed dates.
The indictment also alleges that beneficiaries were encouraged to begin or continue costly treatment through misrepresented expenses, waived copayments, free medical supplies, jewelry, and a leather recliner, adding patient-directed inducements to the referral-payment theory.
Terminal illness requires careful reporting because seriously ill people can still need skilled wound management for pain, infection, odor, drainage, bleeding, comfort, and dignity, even when complete healing within remaining lifespans is unlikely or impossible.
The prosecution’s narrower contention is that certain expensive restorative products could not achieve the purpose represented to Medicare, while defense experts may argue that prognosis, partial improvement, symptom reduction, or reasonable clinical judgment supported disputed care.
Nothing in the indictment’s public summary identifies Medicare beneficiaries as charged participants, and coverage should avoid blaming vulnerable patients merely because they accepted treatment, supplies, cost accommodations, gifts, or professional recommendations presented by trusted clinicians.
Seizure figures remain separate from the bond
Federal officials report that approximately $11.8 million in assets was seized in connection with the investigation, while the indictment seeks larger forfeiture money judgments attributed individually to Tesar, Presha, and Evans if legally qualifying proceeds are established.
The charging document lists seized funds associated with specified financial accounts, yet restraint preserves disputed property during litigation and does not conclusively establish ownership, traceability, criminal proceeds, loss, restitution, or final entitlement to forfeiture.
Prosecutors also allege scheme proceeds funded more than $215,000 in Tampa Bay Buccaneers tickets and a luxury suite, along with more than $400,000 in fine art purchases likely intended to illustrate motive and personal benefit.
Lavish spending can shape a compelling courtroom narrative, but expensive purchases do not independently prove that a particular allograft was unnecessary, a service never occurred, a medical record was falsified, or a transfer rewarded referral.
The release decision likewise should not be inferred from the amount already seized, because a court can impose an unsecured bond based upon the full statutory record even when the government separately controls substantial disputed assets.
Bond, billing, alleged program loss, seizure, forfeiture, restitution, personal gain, and punishment are therefore different legal concepts whose dollar values should never be combined within public reporting into one exaggerated measure of established wrongdoing.
Evidence must connect medicine, records, and money
Medical experts may evaluate wound type, size, infection, circulation, conservative treatment, healing trajectory, restoration potential, product selection, application frequency, and palliative objectives for every beneficiary identified by prosecutors within the five charged fraud executions.
Electronic records may reveal when notes were created, copied, revised, signed, or supplemented, while image metadata and access logs could test allegations involving retrospective documentation, incorrect service dates, nonexistent treatment, or disputed authorship.
Financial evidence may trace Medicare payments into Primecare, product payments toward the distributor, invoice assignments to particular representatives, percentage calculations, business-account deposits, later transfers, and expenditures the government identifies as personal benefits during the alleged period.
Communications could connect those datasets by showing what participants understood about patients, prices, product changes, invoices, reimbursement, compensation, audits, and secrecy, although the defense can demand complete threads and context for every excerpt.
Beneficiaries, caregivers, employees, distributor personnel, and other clinicians may provide firsthand accounts, but repeated treatment, serious illness, divided responsibilities, unfamiliar materials, and fading memory can complicate testimony that must be compared with contemporaneous records.
Every count remains defendant-specific, meaning proof that Tesar caused one false claim would not automatically establish Evans knowingly received a kickback, while proof of Presha’s deposit would not automatically establish every Primecare treatment fraudulent.
The government retains the burden of proving each charged offense beyond a reasonable doubt, and the June 18 release order neither lowers that burden nor supplies an evidentiary shortcut for the claims, records, payments, or agreements prosecutors dispute.
Public consequences began immediately after arrest
An arrest followed by a seven-figure bond headline can affect professional licensing, Medicare enrollment, employment, banking, patients, referral partners, and online search results long before discovery, expert testimony, motions, pleas, or verdicts clarify the allegations.
The unsecured structure creates another communication challenge because audiences may incorrectly interpret release as leniency purchased with cash, while others may treat a large nominal amount as judicial confirmation that the accusations are already proven.
Organizations facing comparable scrutiny may require disciplined crisis public relations management that coordinates verified statements with counsel, preserves evidence, respects release conditions, corrects demonstrable inaccuracies, and avoids declaring guilt or exoneration before adjudication.
Longer-term reputation rebuilding strategies can present accurate procedural updates, documented compliance reforms, verified credentials, and meaningful accountability without erasing legitimate reporting, manipulating public records, intimidating critics, or concealing information relevant to patients and regulators.
Nothing in the reviewed public materials indicates that Amicus International Consulting represents Tesar, Presha, Evans, Primecare, the unnamed distributor, or any connected person or business involved in or responding to the unresolved federal prosecution.
Responsible updates should give later dismissals, pleas, acquittals, convictions, sentences, restitution orders, forfeiture decisions, bond modifications, or trial postponements prominence comparable with the original arrest, especially when older search results remain permanently accessible.
What the bond update establishes now
The present record establishes a limited procedural picture: Tesar was arrested June 18, appeared before a federal magistrate judge that day, obtained conditional release, and executed a $1 million unsecured appearance bond while awaiting further proceedings.
Her release order restricted travel to the Middle District of Florida; later motions sought temporary permission to travel beyond that boundary, and no accessible docket summary reviewed through August 10 identifies a subsequent revocation of release.
The merits record remains entirely different, because prosecutors still must prove five alleged fraud executions, the charged conspiracy, and two alleged kickback payments through admissible patient, clinical, corporate, electronic, and financial evidence presented in court.
Defense counsel retains the opportunity to dispute whether services occurred, whether treatment was reasonable, whether records were knowingly false, whether payments rewarded referrals, whether calculations are accurate, and whether Tesar joined any unlawful agreement.
The January 2027 trial setting gives both sides additional preparation time but predicts no result, and future motions, negotiated resolutions, evidentiary rulings, scheduling changes, or a jury trial could materially reshape the case.
Until a valid plea or verdict establishes otherwise, Leigh Tesar remains presumed innocent, and her bond should be understood as conditional pretrial release following arrest rather than evidence that the government’s Medicare fraud allegations have been proven.